1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHLindolent B-cell non-Hodgkin lymphomaRecruitingPhase 1 / Phase 22026-10-02NCT03571568